Mereo BioPharma Group plc MREO

Set alert

Price alert · MREO

All alert types
0.29 USD 0.00 +0.17%

At close

0.29 0.00 -0.72%

Pre-market · Nov 3, 4:00 AM ET

Bid
0.29 × 3
Ask
0.29 × 2
0.2801 Day range 0.299
0.20 52-week range 2.37
YTD
-30.46%
1 year
-84.74%
Open
0.2862
Prev close
0.2895
Mkt cap
46.31M
Vol
482.60K
Avg vol
3.96M
EPS
-0.20
P/E
0.00
Div yield
0.00%
More statistics
Low
0.2801
High
0.299
Forward P/E
-113.00
Beta
0.00
Short ratio
8.10
Inst. own
70.58%
Dividend
0.00
Ex-div date
Earnings
Aug 13, 2024
50-d avg
3.92
200-d avg
3.73
1y target
7.04

5D chart

Chart tools
Interval

Signals (145)
NameTimeAgo
SMA: BullishNov 2, 3:50 PM14 hours ago
SMA: BullishNov 2, 3:45 PM14 hours ago
MACD: Buy SignalNov 2, 3:45 PM14 hours ago
SMA: BearishNov 2, 2:30 PM15 hours ago
SMA: BullishNov 2, 2:20 PM15 hours ago
SMA: BearishNov 2, 1:35 PM16 hours ago
SMA: BullishNov 2, 1:30 PM16 hours ago
SMA: BearishNov 2, 1:20 PM16 hours ago
SMA: BullishNov 2, 1:00 PM16 hours ago
MACD: Sell SignalNov 2, 12:20 PM17 hours ago
SMA: BearishNov 2, 12:15 PM17 hours ago
SMA: BearishNov 2, 12:15 PM17 hours ago
MACD: Buy SignalNov 2, 11:40 AM18 hours ago
SMA: BullishNov 2, 11:35 AM18 hours ago
SMA: BullishNov 2, 11:35 AM18 hours ago
SMA: BearishNov 2, 11:10 AM18 hours ago
SMA: BearishNov 2, 11:10 AM18 hours ago
MACD: Sell SignalNov 2, 11:10 AM18 hours ago
SMA: BullishNov 2, 10:55 AM19 hours ago
SMA: BullishNov 2, 10:55 AM19 hours ago

Newest 20 of 145.

Analyst view

Consensus: none

Price target (mean) 7.04 +2326.8% upside
Target (low)
5.91
Target (mean)
7.04
Target (high)
7.87
Ratings (0m) 6 6 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy5
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6
  • 1 month ago 5
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MREO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.0076-0.016 – 0.0780.000.0%9.48M0.0%5
Next quarter-0.008-0.016 – 0.000.000.0%6.59M0.0%4
Current year-0.0298-0.055 – 0.047-0.03168+5.9%9.48M+19.7%5
Next year-0.0312-0.047 – 0.008-0.0298-4.7%10.39M+9.7%5

Upgrades and downgrades

The latest rating changes

MREO analyst upgrades and downgrades
DateFirmActionFromTo
Dec 6, 2024JefferiesInitiated—Buy
Nov 12, 2024NeedhamReiteratedBuyBuy
Oct 1, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Sep 16, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Aug 13, 2024NeedhamReiteratedBuyBuy
Jul 22, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Jun 20, 2024Leerink PartnersMaintainedOutperformOutperform
Jun 13, 2024BairdInitiated—Outperform
Jun 12, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Jun 12, 2024NeedhamMaintainedBuyBuy
May 16, 2024Cantor FitzgeraldReiteratedOverweightOverweight
May 16, 2024NeedhamReiteratedBuyBuy
Apr 10, 2024NeedhamReiteratedBuyBuy
Mar 28, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Mar 28, 2024NeedhamMaintainedBuyBuy
Mar 22, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Sep 8, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Sep 8, 2023NeedhamReiteratedBuyBuy
Aug 23, 2023NeedhamReiteratedBuyBuy
Jun 6, 2023NeedhamReiteratedBuyBuy
May 26, 2023NeedhamReiteratedBuyBuy
Apr 21, 2023NeedhamReiterated—Buy
Mar 30, 2023NeedhamReiterated—Buy
Nov 10, 2022SVB LeerinkMaintained—Outperform
Aug 12, 2022Cantor FitzgeraldInitiated—Overweight
Jun 6, 2022NeedhamMaintained—Buy
May 5, 2021BTIGInitiated—Buy
Apr 5, 2021NeedhamInitiated—Buy